ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Khosla And Otter Fund Ag Biotech Firm

by Marc S. Reisch
April 14, 2014 | APPEARED IN VOLUME 92, ISSUE 15

BioConsortia has raised $15 million from the venture capital firms Khosla Ventures and Otter Capital. The money will advance the Davis, Calif.-based company’s technology for selecting communities of beneficial fungi and bacteria to increase crop yields. Khosla had earlier provided $4 million in seed capital. Last month BioConsortia hired Marcus Meadows-Smith as CEO. Meadows-Smith previously led biopesticide maker AgraQuest, which Bayer CropScience acquired in 2012 for $425 million.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment